| [1] |
Chen X, Du P, She J, et al. Loss of ZG16 is regulated by miR-196a and contributes to stemness and progression of colorectal cancer[J]. Oncotarget, 2016, 7(52):86695-86703.
|
| [2] |
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T) Method[J]. Methods, 2001, 25(4):402-408.
|
| [3] |
Cronshagen U, Voland P, Kern HF. cDNA cloning and characterization of a novel 16 kDa protein located in zymogen granules of rat pancreas and goblet cells of the gut[J]. European Journal of Cell Biology, 1994, 65(2):366-377.
|
| [4] |
Kleene R, Dartsch H, Kern HF. The secretory lectin ZG16p mediates sorting of enzyme proteins to the zymogen granule membrane in pancreatic acinar cells[J]. European Journal of Cell Biology, 1999, 78(2):79-90.
|
| [5] |
Schmidt K, Schrader M, Kern HF, et al. Regulated apical secretion of zymogens in rat pancreas. Involvement of the glycosylphosphatidylinositol-anchored glycoprotein GP-2, the lectin ZG16p, and cholesterol-glycosphingolipid-enriched microdomains[J]. Journal of Biological Chemistry, 2001, 276(17):14315-14323.
|
| [6] |
Kim M, Lee S, Yang SK, et al. Differential expression in histologically normal crypts of ulcerative colitis suggests primary crypt disorder[J]. Oncology Reports, 2006, 16(4):663.
|
| [7] |
Wang L, Hahnloser D, Boardman LA, et al. Loss of expression of zymogen granule protein 16 in colorectal cancer[J]. Cancer Research, 2005, 65(9):452.
|
| [8] |
Cullen, Bryan R. Transcription and Processing of Human microRNA Precursors[J]. Molecular Cell, 2004, 16(6):861-865.
|
| [9] |
Angie M, Cheng MWB, Jeffrey Shelton, et al. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis[J]. Nucleic Acids Research, 2005, 33(4):1290-1297.
|
| [10] |
Kimchi ET, Posner MC, Park JO, et al. Progression of Barrett’s Metaplasia to Adenocarcinoma Is Associated with the Suppression of the Transcriptional Programs of Epidermal Differentiation[J]. Cancer Research, 2005, 65(8):3146-3154.
|
| [11] |
Liu X, Lu K, Wang K, et al. MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5[J]. BMC Cancer, 2012, 12(1):348.
|
| [12] |
Sun M, Liu XH, Li JH, et al. MiR-196a is upregulated in gastric cancer and promotes cell proliferation by downregulating p27(kip1)[J]. Molecular Cancer Therapeutics, 2012, 11(4):842.
|
| [13] |
Tsai MM, Wang CS, Tsai CY, et al. Circulating microRNA-196a/b are novel biomarkers associated with metastatic gastric cancer[J]. European Journal of Cancer, 2016, 64:137-148.
|
| [14] |
Cappello F, David S, Rappa F, et al. The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastase[J]. BMC Cancer, 2005, 5(1):139.
|
| [15] |
Pfister K, Radons J, Busch R, et al. Patient survival by Hsp70 membrane phenotype: association with different routes of metastasis[J]. Cancer, 2007, 110(4):926-935.
|
| [16] |
Fariñasarasqueta A, Lijnschoten GV, Moerland E, et al. The BRAF V600E mutation is an independent prognostic factor for survival in stage II and stage III colon cancer patients[J]. Annals of Oncology, 2010, 21(12):2396.
|
| [17] |
Massey AJ, Williamson DS, Browne H, et al. A novel, small molecule inhibitor of Hsc70/Hsp70 potentiates Hsp90 inhibitor induced apoptosis in HCT116 colon carcinoma cells[J]. Cancer Chemotherapy and Pharmacology, 2010, 66(3):535-545.
|
| [18] |
Zhao Y, Oki E, Ando K, et al. The impact of a high-frequency microsatellite instability phenotype on the tumor location-related genetic differences in colorectal cancer[J]. Cancer genetics and cytogenetics, 2010, 196(2):133-139.
|
| [19] |
Clancy C, Burke JP, Kalady MF, et al. BRAF mutation is associated with distinct clinicopathological characteristics in colorectal cancer: a systematic review and meta-analysis[J]. Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 2013, 15(12):711-718.
|
| [20] |
杨姣，傅健飞，钟献, 等. 左右半大肠癌的差异[J]. 国际肿瘤学杂志, 2015, 42(4):305-308.
|